上海三友医疗器械股份有限公司关于实际控制人及一致行动人减持股份计划公告

Core Viewpoint - The announcement details a share reduction plan by the actual controllers of Shanghai Sanyou Medical Instrument Co., Ltd., due to personal financial needs, involving a total reduction of up to 6,669,249 shares, which represents 2.00% of the company's total share capital [3][16]. Group 1: Basic Information - As of the announcement date, the actual controller Xu Nong holds 39,297,975 shares (11.84% of total shares), while Chairman Michael Mingyan Liu holds 30,341,922 shares (9.10% of total shares) [2][3]. - The combined holdings of the actual controllers and their concerted actions amount to 88,187,166 shares, representing 26.45% of the total share capital [2][3]. Group 2: Details of the Reduction Plan - Xu Nong plans to reduce up to 2,212,155 shares (0.66% of total shares) through block trading, while Michael Mingyan Liu intends to reduce up to 4,457,094 shares (1.34% of total shares) [3][4]. - The reduction will take place within three months following the announcement, starting from February 4, 2026, to April 30, 2026, with a limit of 2.00% of total shares for any continuous 90-day period [3][4]. Group 3: Commitments and Restrictions - Xu Nong and Michael Mingyan Liu have committed that the total number of shares reduced through block trading will not exceed 2.00% of the total shares within any continuous 90-day period during the reduction plan [4][16]. - David Fan, a concerted action party, will not participate in this reduction plan [5]. Group 4: Impact on Control and Governance - The planned reduction will not change the actual control of the company, as the control percentage will decrease from 26.45% to 24.45% after the reduction [16]. - The company assures that the reduction will not significantly impact its governance structure or ongoing operations [16].